SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+13.26%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$232M
AUM Growth
+$232M
(-23%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-62.8%
Top 10 Holdings %
Top 10 Hldgs %
36.64%
Holding
63
New
12
Increased
9
Reduced
17
Closed
25
Top Buys
| 1 |
Eli Lilly
LLY
|
$8.14M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
$7.92M |
| 3 |
Abbott
ABT
|
$7.07M |
| 4 |
Universal Health Services
UHS
|
$6.96M |
| 5 |
UnitedHealth
UNH
|
$6.86M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$38M |
| 2 |
Humana
HUM
|
$19.7M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$11.8M |
| 4 |
Smith & Nephew
SNN
|
$11.6M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$9.55M |
Sector Composition
| 1 | Healthcare | 98.4% |
| 2 | Energy | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Abbott
ABT
$231B
| $9.8M | 4.21% | 90,000 +65,000 | +260% | +$7.07M |
|
2
Danaher
DHR
$147B
| $9.69M | 4.17% | 45,000 -35,000 | -44% | -$7.54M |
|
3
Johnson & Johnson
JNJ
$427B
| $8.93M | 3.84% | 60,000 +30,000 | +100% | +$4.47M |
|
|
4
Thermo Fisher Scientific
TMO
$186B
| $8.83M | 3.8% | 20,000 -86,069 | -81% | -$38M |
|
|
5
Humana
HUM
$36.5B
| $8.28M | 3.56% | 20,000 -47,500 | -70% | -$19.7M |
|
6
Molina Healthcare
MOH
$9.8B
| $8.24M | 3.54% | 45,000 +19,000 | +73% | +$3.48M |
|
|
7
Eli Lilly
LLY
$657B
| $8.14M | 3.5% | +55,000 | New | +$8.14M |
|
|
CTLT
8
DELISTED
CATALENT, INC.
CTLT
| $7.92M | 3.41% | +92,500 | New | +$7.92M |
|
9
McKesson
MCK
$85.4B
| $7.82M | 3.36% | 52,500 +20,000 | +62% | +$2.98M |
|
10
Labcorp
LH
$23.1B
| $7.53M | 3.24% | 40,000 -20,000 | -33% | -$3.77M |
|
11
Zimmer Biomet
ZBH
$21B
| $7.49M | 3.22% | 55,000 +30,000 | +120% | +$4.08M |
|
12
HCA Healthcare
HCA
$94.5B
| $7.48M | 3.22% | 60,000 -45,000 | -43% | -$5.61M |
|
|
PPD
13
DELISTED
PPD, Inc. Common Stock
PPD
| $7.4M | 3.18% | 200,000 +50,000 | +33% | +$1.85M |
|
14
Centene
CNC
$14.3B
| $7.29M | 3.14% | 125,000 -45,000 | -26% | -$2.62M |
|
15
Medtronic
MDT
$119B
| $7.27M | 3.13% | 70,000 +10,000 | +17% | +$1.04M |
|
|
16
Universal Health Services
UHS
$11.6B
| $6.96M | 2.99% | +65,000 | New | +$6.96M |
|
|
17
UnitedHealth
UNH
$281B
| $6.86M | 2.95% | +22,000 | New | +$6.86M |
|
18
Baxter International
BAX
$12.7B
| $6.84M | 2.94% | +85,000 | New | +$6.84M |
|
19
Boston Scientific
BSX
$156B
| $6.5M | 2.79% | +170,000 | New | +$6.5M |
|
20
Stryker
SYK
$150B
| $6.25M | 2.69% | 30,000 -30,000 | -50% | -$6.25M |
|
21
Cencora
COR
$56.5B
| $5.82M | 2.5% | 60,000 +35,000 | +140% | +$3.39M |
|
22
Quest Diagnostics
DGX
$20.3B
| $5.73M | 2.46% | 50,000 -75,000 | -60% | -$8.59M |
|
23
Charles River Laboratories
CRL
$8.04B
| $5.66M | 2.43% | +25,000 | New | +$5.66M |
|
24
Avantor
AVTR
$9.18B
| $5.62M | 2.42% | 250,000 +75,000 | +43% | +$1.69M |
|
25
Regeneron Pharmaceuticals
REGN
$61.5B
| $5.6M | 2.41% | 10,000 -5,000 | -33% | -$2.8M |
|